Coulter Partners Top global hires for large-cap, mid-cap and public companies H1-2024

CEO/ C-suite/ Board

Function

Focus area

Location

CEO

Medical equipment (publicly listed)

US/ UK

Chief Development Officer

Biotech (publicly listed)

Europe

Chief R&D Officer

Mental healthcare (publicly listed)

US

Chief Technology Officer

AI-enabled drug discovery (publicly listed)

Europe

Chief, Operations & Supply Chain

Speciality pharma (mid-cap)

Europe

Board Director

Biopharma (publicly listed)

US

Board Director

Novel enzymes (publicly listed)

Nordics

Group General Counsel

Animal health (large-cap)

Europe

 

 

 

Commercial / Functional / Strategic Leadership

Function

Focus area

Location

VP Business Development

Biotech (publicly listed)

US/Canada

VP Sustainability

Generics (publicly listed)

UK

VP Commercial Excellence

Pharma (mid-cap)

Europe

VP Global Total Reward

Generics (mid-cap)

UK

VP Legal

Biopharma (publicly listed)

US

Country Manager

Drug discovery (mid-cap)

Europe

Country Value & Access Lead

Speciality pharma (mid-cap)

Europe

Country Franchise Lead, Metabolic Diseases

Drug discovery (large-cap)

Europe

Business Development and Marketing Director

Diagnostic services (large-cap)

Europe

Commercial Excellence Director

Medical devices (mid-cap)

Europe

 

 

 

R&D/ Medical/ Technical

Function

Focus area

Location

VP Translational Neuroscience

Biotech (large-cap)

US

VP R&D

Specialty pharma (large-cap)

Europe

VP Artificial Intelligence & Informatics

Computational biotech (publicly listed)

UK

VP Pharmacovigilance

Biopharma (publicly listed)

Europe

VP Regulatory

Pharma (mid-cap)

US/ Europe

Head of Medicinal Chemistry

Drug Discovery (publicly listed)

Nordics

Head of Global Technical Operations

Biopharma (mid-cap)

Europe

Head of PK/PD and Toxicology

Specialty pharma (large-cap)

Europe

Executive Director, Non-Rx R&D

Specialty Pharma (mid-cap)

Europe

Regional Medical Affairs Lead

Pharma (mid-cap)

Nordics